Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Michel R. Langlois, M. John Chapman, Christa Cobbaert, Samia Mora, Alan T. Remaley, Emilio Ros, Gerald F. Watts, Jan Borén, Hannsjörg Baum, Eric Bruckert, Alberico Catapano, Olivier S. Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Anne Langsted, Kari Pulkki, Nader Rifai, Grazyna Sypniewska, Olov Wiklund, B∅rge G. Nordestgaard
  • Clinical Chemistry, May 2018, AACC
  • DOI: 10.1373/clinchem.2018.287037

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1373/clinchem.2018.287037

In partnership with: